Erosions sometime seen in normal people and people who are acpa positive and arthralgia OP0133 @RheumNow #EULAR2019 https://t.co/xuod6RBGiI

Plenty happening in ANCA-assoc vasculitis - just a taste of recent insights into induction therapy: pulse methylpred does not improve survival but increases sepsis and diabetes, MMF similar induction rates to CYC but more relapses #EULAR2019 SP0044 from Raashid Luqmani @RheumNow https://t.co/3VhxaAPZm9 https://t.co/BdhbLSzNC1

• Rachel Black on Twitter: "Pulse methylpred does not improve survival or re…

Kinesiophobia Fear that exercise might cause a flare of RA/pain Hopefully, rheumatologists don’t add to this in how we handle Qs on exercise. My bias is multidisciplinary care, working with interested physios & exercise physiologists matters #eular2019

Is RA getting milder? Swedish registry of 6559 new DMARD naive #RA pts followed since 1991 shows signif decline in SJC TJC CRP ESR, increase in global assessment and shorter time to Dx. #EULAR2019 THU0063 https://t.co/LMeJVpg5uF

The role of uric acid in #FattyLiver #Gout #MetabolicSyndrome - Miguel Lanaspa #EULAR2019 https://t.co/zD2VplHUMt

Excellent summary of various benefits of #aerobic & #strength training #exercise at various timepoints via @GeorgeMetsios #EULAR2019 Good to know when prescribing exercise & guiding patients with rheumatic musculoskeletal conditions 👍🏼 https://t.co/qw0GeEj8Xj

Current @eular_org guidelines for management of ANCA vasculitis #EULAR2019 https://t.co/3Yh0uKYuKx

Treating Fatigue in RA. I’m guilty of not addressing 1,2&5 well #EULAR2019 https://t.co/NBvVr4aF1P

In anti-CCP positive patients with arthralgias but no clinical synovitis, the more Power Doppler signal, the more likely future inflamm arthritis #EULAR2019 THU0072 Paul Emery’s Leeds group @RheumNow https://t.co/QsQ2BV0qKC

#PhysicalActivity has some evidence for improving rheumatic disease activity & #inflammation ⬇️ESR ⬇️IL-17a ⬇️IL-18 ⬇️TNF alpha receptors ⬆️IL-6 via @NoreleeK #EULAR2019 #exercise #arthritis https://t.co/RtARGnbQta

In this week's issue for #EULAR2019: Upadacitinib as monotherapy in patients with active #rheumatoidarthritis and inadequate response to methotrexate (SELECT-MONOTHERAPY): a randomised, placebo-controlled, double-blind phase 3 study https://t.co/hyAKuBPVtJ https://t.co/xSnHZFZtKo

• DEFINE_ME

Do you really believe that @_connectedcare ? https://t.co/QmGFTOLCyK

• Dr Irwin Lim on Twitter: "We’re getting closer to something we can use…

We’re getting closer to something we can use.....RT @sylba2308: New targets in #osteoarthritis #EULAR2019 https://t.co/sBEkeJuPza

Contemporary epidemiology of gout in the UK population.. #EULAR2019 @KeeleUniversity #Gout https://t.co/lcNz84InBL

Interesting politic that may exist between the 2 authoritative bodies on axial vs peripheral SpA #eular2019 https://t.co/Ksc4C3iELj